1-8 of 8
Shella Saint Fleur-Lominy
Close
Sort by
Journal Articles

Assessing the Safety of Discharging Patients Receiving High-Dose Methotrexate with Levels Greater Than 0.1 Umol/L

Elaine Xiang, Jamie Chin, Jonathan Weltz, Aaron Sango, Meredith Akerman, Michael L. Grossbard, Shella Saint Fleur-Lominy
Journal: Blood
Blood (2022) 140 (Supplement 1): 10806–10807.
https://doi.org/10.1182/blood-2022-167207
Published: 2022
Journal Articles

Evaluating the Safety of Outpatient Ramp up of Venetoclax in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Elaine Xiang, Frank Cirrone, Jamie Chin, Meredith Akerman, Shella Saint Fleur-Lominy, Maher Abdul Hay
Journal: Blood
Blood (2021) 138 (Supplement 1): 2311.
https://doi.org/10.1182/blood-2021-145057
Published: 2021
Journal Articles

Pegasperagase Toxicity in Adult Patients with Acute Lymphoblastic Leukemia: A Single Center Experience Comparing Patients Older and Younger Than 35 Years of Age

Jun H Choi, MD, Jacques Azzi, MD, Tsivia Hochman, MS, Mary Lynn R. Nierodzik, MD, Shella Saint Fleur-Lominy, MD PhD, Maher Abdul Hay, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5067.
https://doi.org/10.1182/blood-2019-129041
Published: 2019
Journal Articles

NSD2 Mutations in Pediatric ALL Leads to a Distinct Gene Expression Profile and Epigenetic Landscape That Is Cell Context Specific

Joanna Pierro, DO, Jason Saliba, PhD, Nikki Ann Evensen, PhD BS, William L. Carroll, MD, Gunjan Sethia, MS, Shella Saint Fleur-Lominy, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3905.
https://doi.org/10.1182/blood-2018-99-118535
Published: 2018
Journal Articles

Midostaurin in Combination with Idarubicin and Cytarabine (3+7) Induction for FLT3 Positive AML - Very High Complete Response Rates and Transition to Allogeneic Transplantation

Jacques Azzi, MD, Frank Cirrone, PharmD, Maher Abdul Hay, MD, David Kaminetzky, MD, Kenneth B. Hymes, MD, Maxim Kreditor, MD, Ahmad-Samer Al-Homsi, MD, Michael L. Grossbard, MD, Catherine Diefenbach, MD, Tibor Moskovits, MD, Shella Saint Fleur-Lominy, MD PhD, Bruce G. Raphael, MD, Raoul Tibes, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5216.
https://doi.org/10.1182/blood-2018-99-117314
Published: 2018
Journal Articles

The Role of MMSET E1099K Mutation in Gene Dysregulation, Drug Resistance and Clonogenicity in Acute B-Lymphoblastic Leukemia

Joanna Pierro, DO, Jason Saliba, PhD, Nikki Ann Evensen, PhD BS, Yixiao Gong, Shella Saint Fleur-Lominy, MDPhD, William L. Carroll, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2474.
https://doi.org/10.1182/blood.V130.Suppl_1.2474.2474
Published: 2017
Journal Articles

Genomic and Epigenetic Effects of DNA Methyltransferase Inhibition in Acute Lymphoblastic Leukemia

Shella Saint Fleur-Lominy, MDPhD, Teena Bhatla, MD, Stephen Kelly, MS, Varshini Vasudevaraja, MS, Aristotelis Tsirigos, PhD, William L. Carroll, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2479.
https://doi.org/10.1182/blood.V130.Suppl_1.2479.2479
Published: 2017
Journal Articles

Crac Channel Deletion in Leukemic Cells Delays Progression of Leukemia and Prolongs Survival of Mice with Notch-1-Induced T-Cell Acute Lymphoblastic Leukemia

Shella Saint Fleur-Lominy, MD PhD, Mate Maus, PhD, Stefan Feske, MD
Journal: Blood
Blood (2015) 126 (23): 1433.
https://doi.org/10.1182/blood.V126.23.1433.1433
Published: 2015